Highest-materiality recent filing
Nxu terminates merger, board approves winding down; President and CFO resign
Terminated merger with Verde Bioresins on June 23, 2025; closing conditions not met.
Nxu receives Nasdaq delisting determination; company will not appeal
June 10, 2025: Nasdaq Panel denies exception; delists Nxu for failing to maintain $1.00 bid price after reverse stock split.
Reverse stock split (1-for-20) effective March 31 did not cure minimum bid price deficiency by extended compliance deadline.
Nxu announces 1-for-20 reverse stock split effective March 31, 2025
Reverse stock split at 1-for-20 ratio effective 12:01 a.m. ET on March 31, 2025.
Nxu stockholders approve merger with Verde Bioresins, reverse stock split, and name change
All 11 proposals approved at February 11, 2025 special meeting.
Nxu enters $3M PIPE with warrants and voting agreements tied to Verde Bioresins merger
Issued 6.8M shares + pre-funded warrants for 5.2M shares at $0.0001 exercise price.
Nxu files S-4 for merger with Verde; Verde holders to own ~95% of combined co.
Nxu filed S-4 with SEC for all-stock merger with Verde Bioresins; closing expected Q1 2025.
Nxu to merge with Verde Bioresins; Verde stockholders to own ~95% post-merger
Nxu enterprise value ~$16.2M; Verde ~$306.9M; Verde stockholders ~95% post-merger.
Nxu receives Nasdaq non-compliance notice over audit committee vacancy
Nasdaq notified Nxu on Sept 4, 2024 that audit committee fails requirement after director Caryn Nightengale did not stand for re-election.
Nxu shareholders approve reverse stock split authorization, 48M share increase in incentive plan
Shareholders approved charter amendment permitting reverse stock split approval by majority of votes cast; filed Aug 16, 2024.
Nxu cuts headcount, evaluates strategic alternatives including potential business combination
Committed to headcount reduction across product, engineering, manufacturing, and G&A; expects completion by May 10, 2024.
Nxu receives Nasdaq delisting notice for bid price non-compliance; 180-day cure to Sep 30, 2024
On April 2, 2024, Nxu received Nasdaq notice for failing to meet $1.00 minimum bid price continued listing requirement.
Nxu fully regains Nasdaq compliance; Bid Price, Equity, and Annual Meeting rules cured
Nasdaq confirmed on Feb 13, 2024 that Nxu demonstrated compliance with Bid Price and Equity listing rules, beating April 7 deadline.
Nxu receives Nasdaq notice for failure to hold annual meeting, faces additional delisting basis
Nasdaq notified Nxu on Jan 9, 2024 of failure to hold annual meeting within 12 months of FY2022 end, violating Rule 5620(a).
Nxu acquires 15% of Lynx Motors via share exchange; executes 1-for-150 reverse stock split
Acquired 15% of Lynx Motors; issued 1,000 Series A preferred shares convertible into common, valued at $3M.
Nxu approves 1-for-150 reverse stock split to regain Nasdaq $1.00 minimum bid compliance
Board approved a 1-for-150 reverse stock split of Class A common stock, effective after market close Dec 26, 2023.
Nasdaq grants Nxu continued listing subject to compliance by April 7, 2024
Nasdaq Hearings Panel approved Nxu's request for continued listing on Dec. 18, 2023.
Nxu CFO Apoorv Dwivedi resigns effective Jan 12, 2024; VP of Finance Sarah Wyant named interim CFO
CFO Apoorv Dwivedi resigned effective Jan 12, 2024 to pursue other opportunities; no material disagreements.
Nxu enters $14.7M at-the-market equity offering with H.C. Wainwright
Up to $14,726,892 of Class A common stock may be sold at the market through H.C. Wainwright as sales agent.
Nxu closes $3.0M public offering of 86M shares at $0.035/share
Offering of 86,000,000 shares of Class A common stock at $0.035 per share, gross proceeds ~$3.0M.
Nxu receives Nasdaq delisting notice; hearing set for Dec 14, 2023
On Oct 10, 2023, Nasdaq notified Nxu of non-compliance with minimum bid price rule (Listing Rule 5550(a)).
Received delisting notice for failing Nasdaq's stockholders' equity minimum ($2.5M) and minimum bid price ($1.00).
Nxu receives Nasdaq delisting notice for bid price non-compliance, plans hearing
Nasdaq notified Nxu on Oct 10, 2023 that common stock will be suspended on Oct 19 unless hearing requested.
Nxu receives Nasdaq delisting notice for failing $2.5M equity requirement
Received Nasdaq notice on Aug 29, 2023: stockholders' equity below $2.5M minimum.
Atlis Motor Vehicles completes reorganization merger with Nxu; Nxu to trade under NXU ticker
On May 12, 2023, Atlis merged with Nxu Merger Sub, becoming a wholly-owned subsidiary of Nxu; all Atlis shares converted to Nxu shares on one-for-one basis.
All Atlis Class A and Class D shares converted 1:1 into Nxu Class A and Class B common stock.
Atlis stockholders approve reorganization merger and Nxu 2023 Omnibus Incentive Plan
Stockholders approved the Holding Company Proposal for Atlis to be replaced by Nxu as the public company.
Atlis Motor Vehicles proposes rebranding as Nxu, Inc. and holding company reorganization
Atlis to become operating subsidiary of new holding company Nxu, Inc., subject to stockholder vote.
Nasdaq notice for bid price below $1.00 per share; 180-day cure period runs to Oct 8, 2023.
Atlis Motor Vehicles closes $13M public offering of 8.3M units at $1.56/unit
Offering of 8,334,000 units closed Feb 21, 2023; each unit includes 1 share (or pre-funded warrant), 0.65 Series A warrants, and 0.75 Series B warrants.
Atlis Motor Vehicles closes $10M second tranche of convertible notes and warrants, netting $9M
Investors exercised rights to purchase $5.0M each in 10% discount convertible notes and warrants for total $10.0M principal, $9.0M gross proceeds.
Amends Nov 2022 Securities Purchase Agreement: second tranche up to $10M base + $5M oversubscription of 10% discount convertible notes and warrants.
Atlis Motor Vehicles raises up to $27M via 10% discount convertible notes and warrants
Issued up to $30M principal of Senior Secured 10% Discount Convertible Notes; gross proceeds up to $27M.
On June 16, 2025, the Company received notices of resignation from Annie Pratt, resigning from her role as President of the Company and from the Board, and Sarah Wyant, resigning from her role as Chief Financial Officer of the Company, each effective as of June 16, 2025.
On June 16, 2025, the Company received notices of resignation from Annie Pratt, resigning from her role as President of the Company and from the Board, and Sarah Wyant, resigning from her role as Chief Financial Officer of the Company, each effective as of June 16, 2025.
On June 23, 2025, Jessica Billingsley resigned from the Board, effective as of June 23, 2025.
On January 13, 2025, the Board of Directors (the “Board”) of Nxu, Inc. (the “Company”) elected Erin Essenmacher to serve as a director on the Board, effective immediately, to fill the vacancy on the Board.
The Nxu Board also appointed Sarah Wyant (together with the Executives, the “Nxu Executives”), Nxu’s Interim Chief Financial Officer, to serve as Nxu’s Chief Financial Officer, effective on October 23, 2024.
On April 17, 2024, Caryn Nightengale notified the board of directors (the “Board”) of Nxu, Inc (the ”Company”) of her decision not to stand for reelection to the Board at the expiration of her current term at the Company’s 2024 Annual Metting of Stockholders (the “2024 Annual Meeting”) scheduled for June 14, 2024.
In the interim, the Company’s Vice President of Finance, Sarah Wyant, will be named Interim Chief Financial Officer and will assume the duties as the principal financial officer and principal accounting officer for the Company.
On December 4, 2023 Nxu, Inc. (the “Company”) received a notice of resignation from its Chief Financial Officer, Apoorv Dwivedi, effective January 12, 2024.
on June 20, 2023, the Board of Directors (the “Board”) of the Company elected Jessica Billingsley as an independent director.
the directors of Atlis immediately following the consummation of the Reorganization Merger, but prior to the completion of the Conversion, were Mark Hanchett, Annie Pratt, Britt Ide and Caryn Nightengale.
the directors of Atlis immediately following the consummation of the Reorganization Merger, but prior to the completion of the Conversion, were Mark Hanchett, Annie Pratt, Britt Ide and Caryn Nightengale.
the directors of Atlis immediately following the consummation of the Reorganization Merger, but prior to the completion of the Conversion, were Mark Hanchett, Annie Pratt, Britt Ide and Caryn Nightengale.
Max materiality 0.95 · Median 0.68 · Most common event other_material